NCT02592356 2024-03-05Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerM.D. Anderson Cancer CenterPhase NA Completed23 enrolled
NCT03008369 2024-02-20Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by SurgeryMayo ClinicPhase 2 Completed3 enrolled 9 charts